Advancing Medtech’s Digital Opportunity to Meet the Moment

Moderator: Mark Ginestro, Principal, Life Sciences, EY-Parthenon

Mark advises companies in all facets of corporate development. He focuses on the health care and life sciences industries with experience in pharmaceuticals, biotechnology, medical device, diagnostics and health care distribution. He has over 25 years of experience in growth strategy, portfolio strategy, M&A strategy, M&A diligence, and acquisition integration and divestiture carve-out. 

John Babitt, Partner, Life Sciences

John is a partner with over 30 years of experience, all in the life sciences and health care industry.

He advises strategic and private equity life science clients on various projects, including M&A, supply chain, IT, and financial and tax considerations. John has extensive experience across all sectors of life sciences with a focus on medical technology.

Shaye Mandle, Executive Director, AdvaMed Digital Health Tech

Shaye is an accomplished corporate, association, and government executive with more than 25 years of experience in innovation sectors and public policy, including healthcare, technology, entrepreneurship, national defense, and economic development. Shaye has served on multiple Boards and advisory committees, including major research universities and public sector appointments.

Maryline Marquet, Partner, MedTech Lead, EMEIA Digital Transformation Architect, Ernst & Young AG

Maryline is a MedTech and Life Sciences professional with over 20 years of business and digital transformation experience. She focuses on improving patient outcomes by designing health care solutions that prioritize patients and digital tech.

Maryline previously held sales and marketing management positions in the healthcare and pharmaceutical industries, led commercial operations at a Singapore-based health tech start-ups, and was responsible for 31 countries’ patient engagement strategies and new partnerships in the pharmaceutical sector.

Jay Zhu, EY-Parthenon Principal, Strategy and Transactions

Jay is a principal at EY-Parthenon and a leading advisor to global medical technologies and pharmaceutical companies on a wide range of strategy, commercial and M&A issues.

During his 20 years of consulting, Jay has helped more than 100 medical technologies, pharmaceutical and health care companies develop and execute organic and inorganic strategies to drive growth and transformation in the US, Europe, Asia-Pacific and Latin America markets.